Viruses have evolved strategies that highlight critical, intertwined host immune mechanisms. As 17 postulated by the missing-self hypothesis, natural killer (NK) cells and major histocompatibility complex 18 class I (MHC-I)-restricted cytotoxic T lymphocytes (CTLs) have opposing requirements for ubiquitously 19 expressed MHC-I molecules. Since NK cell MHC-I-specific Ly49 inhibitory receptors prevent killing of cells 20 with normal MHC-I, viruses evading CTLs by down-regulating MHC-I should be vulnerable to NK cells. 21
Introduction 28
Viruses and their hosts are engaged in an evolutionary "arms race," highlighting host immune 29 mechanisms. A critical mechanism involves recognition of virus-infected cells by cytotoxic lymphocytes 30 that trigger exocytic release of perforin and granzymes to kill infected cells. While virus-specific CD8 + 31 cytotoxic T lymphocytes (CTLs) recognize viral peptides presented by MHC class I molecules (MHC-I) on 32 infected cells, viruses can specifically down-regulate MHC-I, nearly ubiquitously expressed as self, to 33 evade CTL effector responses [1, 2] . The missing-self hypothesis predicts that NK cells should kill cells 34 that downregulate MHC-I [3] , as supported by MHC-I-specific inhibitory NK cell receptors that prevent 35 NK cell killing of cells with normal MHC-I expression in vitro [4, 5] . However, the role of inhibitory NK cell 36 receptors during in vivo responses is still poorly understood. 37 38 In mice, the Ly49 NK cell receptor family is encoded in a gene cluster in the NK gene complex (NKC) on 39 mouse chromosome 6 [6] . While Ly49s display profound allelic polymorphisms with several haplotypes 40 and allelic forms, [7] most Ly49s mediate inhibitory function in effector responses through their 41 cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs) [8] . Inhibitory Ly49 receptors bind 42 MHC-I alleles but their specificities are incompletely understood regarding in vivo function and are 43 reportedly identical, e.g., Ly49A B6 , Ly49C B6 , Ly49G B6 , and Ly49I B6 recognize H2D d [9, 10] . Ly49s are 44 stochastically expressed on overlapping subsets of NK cells with individual NK cells simultaneously 45 expressing two or more Ly49s. Only receptors specific for self-MHC-I in vivo appear to provide a second 46 function in conferring the licensed phenotype whereby licensed NK cells exhibit enhanced 47 responsiveness to stimulation through activation receptors in vitro [11] . However, due to the potential 48 role of other receptors [12, 13] , definitive evidence that MHC-I-dependent licensing plays a role in NK 49 cell function in vivo has not been established . 50 In contrast to inhibitory Ly49s, Ly49 activation receptors lack ITIMs and are coupled to immunoreceptor 52 tyrosine-based activation motif (ITAM)-containing chains, e.g. DAP12 [8] . The Ly49H B6 activation 53 receptor is responsible for genetic resistance of C57BL/6 (B6) mice to murine cytomegalovirus (MCMV) 54 infection, providing vital early viral control, even in mice with intact adaptive immunity [14] . Ly49H B6 55 recognizes an MCMV-encoded MHC-I-like molecule, m157 [15] . The Ly49P1 NOD/Ltj , Ly49L BALB , and 56 Ly49D2 PWK/Pas activation receptors serve similar functions, albeit with ligands distinct from m157 [16] . 57
Additionally, the inhibitory Ly49I 129 receptor also binds m157 [15, 17] , suggesting that inhibitory Ly49 58 receptors play critical roles in viral control, although effects on licensed NK cells also require 59 consideration. 60 61 Indeed, prior studies suggested that licensed NK cells hamper MCMV control through inhibitory 62 receptors for host MHC-I [18] . However, other studies suggest that inhibitory Ly49s may enhance MCMV 63 control, but these approaches have utilized mouse strains with poorly characterized Ly49s and Ly49 64 depleting antibodies with unclear specificities and that also affect total NK cell number, confounding 65 interpretations [16, 19, 20] . Thus, the in vivo role of licensed NK cells and inhibitory Ly49s in viral 66 infections is incompletely understood. 67 68 Herein, we used CRISPR-Cas9 to simultaneously and cleanly target multiple Ly49 receptors, allowing 69 definitive evaluation of the role of Ly49s in missing-self rejection and resistance to MCMV infection. In 70 turn, we studied how MCMV modulates these host responses. 71
Results 72
MHC-restricted, NK cell-dependent protection against MCMV in mice 73
To investigate the role of NK cells in MCMV control in different MHC backgrounds, we utilized C57BL/10 74 (B10, H2 b ) and B10.D2 (H2 d ) MHC-congenic mouse strains that are closely related to B6 (H2 b ) and share 75
Ly49 haplotypes [21] . Susceptibility at day 4 post-infection (d4 p.i.) to wild-type (WT)-MCMV in B10 mice 76 was NK cell-dependent, and antibody blocking studies showed protection against WT-MCMV was 77 dependent upon Ly49H (Fig 1A) as shown for B6 mice [14] . To examine other mechanisms of viral 78 resistance applicable to MCMV isolates from the wild lacking m157 [17] , we used Δm157-MCMV that 79 contains a single nucleotide deletion in m157 that prevents full-length expression. Although B10 mice 80
were unable to control Δm157-MCMV infection at d4 p.i., MHC-congenic B10.D2 (H2 d ) mice were 81 resistant (Fig 1B) , demonstrating an MHC-restricted effect. 82
83
To isolate the MHC-restricted effect to a single MHC-I allele, we showed Δm157-MCMV resistance in B6 84 mice transgenically expressing only H2D d , in the genetic absence of H2K b and H2D b (D8-KODO), 85 comparable to B10.D2 mice (Fig 1C) , indicating resistance was specifically due to H2D d . Resistance was 86 clearly dependent upon NK cells but not CD8 + T cells, as shown by antibody depletion of NK or CD8 + T 87 cells, respectively (Fig 1B, C) . Thus, MHC-restricted resistance to Δm157-MCMV is due to H2D d and is NK 88 cell-dependent. 89 90 Perforin-deficient (Prf1 -/-) D8-KODO mice were as susceptible as wild type (WT) B6 mice whereas both 91 perforin WT (Prf1 +/+ ) and perforin heterozygous (Prf1 +/-) D8-KODO mice controlled Δm157-MCMV ( Fig  92   1D ). Likewise, granzyme-deficient D8-KODO mice could not control Δm157-MCMV (Fig 1E) . Although 93 NKG2D enhances NK cell responses to MCMV in B6 mice [22, 23] , we found no change in viral control by 94 NKG2D-deficient D8-KODO mice as compared to D8-KODO mice (Fig 1F) . Thus, NK cell-dependent resistance. Similarly, {(D8-KODO x KODO) F1 hybrids} were also resistant (Fig 2B) , indicating that H2D d 119 heterozygosity is sufficient for antiviral protection when Ly49 genes were intact. 120 121 Inhibitory Ly49A and Ly49G receptors are required for H2D d -dependent resistance 122
To decipher which Ly49 receptor(s) are involved in Δm157-MCMV resistance in D8-KODO mice, we first 123 considered Ly49 activation receptors. However, a cross between resistant D8-KODO mice with 124 susceptible B6 (H2 b ) mice generating heterozygosity for H2D d and H2 b resulted in an intermediate 125 infection phenotype (Fig 2B) , highlighting an apparent role of MHC-I context for antiviral protection and 126 contrasting MCMV resistance explained by Ly49 activation receptors when complete reversal was found 127 in crossing susceptible and resistant mice [16, 24, 25] . Nonetheless, since ΔLy49-1 D8-KODO mice had low 128 levels of Ly49D and lacked Ly49h and both receptors require DAP12 (and DAP10 to a lesser extent) for 129 expression, including Ly49H-mediated resistance to MCMV, we evaluated the role of Ly49D and Ly49H 130 by studying D8-KODO mice deficient in DAP10 and DAP12. For reasons not immediately clear, Ly49A, 131
Ly49F and Ly49G expression was markedly decreased ( Fig S2) . Regardless, these mice were still resistant 132 ( Fig 2C) , indicating that activation signals through DAP10/DAP12 are not required, consistent with the 133 lack of involvement of NKG2D (Fig 1E) which also requires DAP10 or DAP12 for surface expression, 134 depending on its isoform (Fig S2) [26] . Thus, Ly49 activation receptors are surprisingly not required for 135 resistance to Δm157-MCMV in D8-KODO mice. 136
137
Having ruled out Ly49 activation receptors, we assessed Ly49 pseudogenes which could theoretically 138 contribute to resistance by splicing events, which has been considered for other Ly49 genes [27, 28] . To 139 test Ly49m (Klra13-ps), harboring a premature stop codon (third exon), we generated four independent 140 CRISPR-Cas9 KO strains. When crossed to D8-KODO background, all four lines showed resistance to 141
Δm157-MCMV, indicating no apparent role for Ly49m (Fig 2D) . Of the other remaining regions of the Ly49 cluster disrupted in the ΔLy49-1 strain, we did not pursue Ly49j, Ly49k and Ly49n because they are 143 predicted to encode severely truncated proteins, not expressed as receptors on NK cells [27] . 144
145
We then turned our attention to Ly49 inhibitory receptors. Since Ly49C and Ly49I reportedly have 146 specificity for H2 d [9, 10] , they could be relevant to ΔLy49-1 D8-KODO mice which express Ly49I but not 147 Ly49C (Fig 2A) . However, lack of these two Ly49s in a new D8-KODO KO strain had no effect on H2D d 148 resistance to Δm157-MCMV which remained entirely dependent upon NK cells (Fig 2E) . 149 150 Finally, we evaluated the potential contribution of Ly49A and Ly49G, since both are deleted in ΔLy49-1 151 mice and there are substantial data indicating that they both recognize H2D d [29, 30] . In D8-KODO mice, 152
Ly49A depletion had no significant change in viral titers while Ly49G depletion moderately increased 153
Δm157-MCMV levels (Fig 3A) . Interestingly, depletion of both Ly49A and Ly49G led to a major loss of 154 viral control, similar to complete NK cell depletion (Fig 3A) , but Ly49G depletion results in approximately 155 50% decrease of all NK cells (Fig S2) . Nonetheless, Ly49D depletion, also affecting 50-60% of NK cells, did 156 not alter viral resistance, suggesting a potential redundant contribution of Ly49A and Ly49G, 157 independent of quantitative NK cell loss. 158
159
To definitively determine the role of Ly49A and Ly49G in resistance, we derived new Ly49 KO strains on 160 the D8-KODO background (Fig S1 and Fig S2) . While deletion of Ly49A alone was insufficient to reverse 161 MCMV resistance, Ly49G depletion in these mice allowed MCMV titers higher than levels with Ly49G 162 depletion in Ly49A-sufficient mice and similar to that with NK cell depletion (Fig 3B) . Reciprocally, Ly49G 163 KO mice were resistant and Ly49A depletion reversed resistance, again comparable to NK cell depletion 164 ( Fig 3C) . Finally, we studied two mouse strains with knockouts of both Ly49A and Ly49G (Ly49AG KO) 165 ( Fig S1) which displayed relatively unchanged NK cell numbers, repertoire of other Ly49s, and development ( Fig S2) . Infection of either Ly49AG KO strain resulted in viral titers similar to NK cell 167 depletion of D8-KODO mice (Fig 3D) and lethality (Fig 3E) . To provide additional evidence, we generated 168
Ly49A knockin (KI) mice (into Ncr1 on chromosome 7) which expressed Ly49A at near normal levels on 169 all NKp46 + NK cells (Fig S3) . ΔLy49-1 Ly49A KI D8-KODO mice demonstrated NK-cell dependent 170 resistance to Δm157-MCMV, unlike susceptible parental ΔLy49-1 D8-KODO mice, showing 171 complementation by Ly49A (Fig 3F) . Therefore, Ly49A and Ly49G act redundantly in H2D d mice to 172 promote NK cell-dependent resistance to Δm157-MCMV, unequivocally establishing the protective role 173 of inhibitory Ly49 receptors in NK cell-dependent viral control. 174
175

NK cell licensing and missing-self rejection both require Ly49A and Ly49G receptors in D8-KODO mice 176
To further delineate the potential mechanism for MHC-restricted viral resistance, we investigated 177 whether loss of Ly49A and Ly49G would have an impact on NK cell licensing by stimulating NK cells from 178 D8-KODO, Ly49AG KO D8-KODO, and TKO (KODO β2m -/-) mice with plate-bound anti-NK1.1 for 179 interferon gamma production [11] . Remarkably, the total NK cell pool in Ly49AG KO D8-KODO mice 180 exhibited significantly reduced IFN-gamma production compared to D8-KODO NK cells and similar to 181 unlicensed NK cells from TKO mice (Fig 4A, B) . These results strongly suggest that Ly49A and Ly49G are 182 required for NK cell licensing through H2D d . 183
184
We next tested whether loss of inhibitory Ly49s would affect missing-self recognition in vivo as 185 suggested by in vitro studies [5, 31] and anti-Ly49 antibody experiments in vivo [32] . Upon injection, 186 labelled KODO (MHC-I-deficient) splenocytes were effectively cleared in D8-KODO mice that were either 187 WT, or lacked only Ly49A or only Ly49G (Fig 4C, S4) , in an NK cell-dependent manner as shown by NK 188 cell depletion (Fig S4A, B) We recently generated KI mice carrying Ly49A with a non-functional ITIM (termed Ly49AYF), 195 demonstrating that effector inhibition and licensing are both mediated by the Ly49A ITIM [31] . Ly49AYF 196 D8-KODO mice were resistant to Δm157-MCMV (Fig 4D) similar to D8-KODO mice but, in contrast to D8-197 KODO mice (Fig 3A, B) , Ly49G depletion led to significantly elevated viral titers, similar to anti-NK1.1 198 depletion (Fig 4D) . These data also mirror Ly49G depletion of Ly49A-KO D8-KODO mice (Fig 3B) , 199
suggesting that Ly49A mediates resistance to Δm157-MCMV in an ITIM-dependent manner. We also 200 observed that Ly49G-depleted Ly49AYF D8-KODO mice were unable to reject missing-self targets, 201
indicating that the ITIM is required for Ly49A to mediate missing-self recognition in vivo (Fig S4) . These 202 findings strongly suggest that Ly49A mediates resistance to Δm157-MCMV in an ITIM-dependent 203 manner. 204
205
MCMV infection generates targets for missing-self rejection 206
We next investigated the mechanism by which Δm157-MCMV might contribute to the Ly49 effects. We 207 initially focused on two MCMV immunoevasins known to downmodulate MHC-I, m06 and m152, [33] 208 although they have variable effects dependent upon MHC-I alleles [34] . To establish their relevance 209 here, we first infected SV40-immortalized D8-KODO MEFs with a GFP-expressing Δm157-MCMV, 210 indicating that H2D d was down-regulated in GFP-positive infected cells (Fig 5A, B) . Next, we produced 211 mutant Δm157-GFP viruses deficient for either m06, m152, or both. Remarkably, H2D d downmodulation 212
was completely abrogated only when both m06 and m152 were targeted (Fig 5A, B) . In contrast, WT 213 m152 (Δm06Δm157 MCMV) or WT m06 (Δm152Δm157 MCMV) decreased surface expression of H2D d in infected cells, consistent with virus-free overexpression systems demonstrating that both m06 [35] and 215 m152 [36] redundantly promote MHC down-regulation. 216 217 D8-KODO mice heterozygous for H2D d (Fig 2B) displayed H2D d expression at an MFI of nearly 50% of 218 homozygous mice (Fig 5C) , comparable to the loss seen during in vitro MCMV infection (Fig 5A, B) . There 219 was a similar level of H2D d expression in (BALB/c x B6)F1 hybrid mice, confirming that physiologically 220 relevant levels of H2D d were being assessed, both in vitro and in vivo. Indeed, heterozygous D8 targets in 221 uninfected homozygous D8-KODO mice were protected from clearance following a 3hr (Fig 5D) or 24hr 222 ( Fig 5E) in vivo cytotoxicity assay. In contrast, KODO targets were completely eliminated at both 24hrs 223 ( Fig 5E) and 48hrs (Fig 4C) , and partially eliminated at 3hrs after injection (Fig 5D) . During MCMV 224 infection, there was enhanced clearance of both MHC-null and MHC-heterozygous targets at all times 225 post-infection (Fig 5D) , consistent with our previous study, where we identified a role for cytokines 226 modulating missing-self rejection during MCMV infection [37] . While heterozygous target cell rejection 227 never reached levels seen with MHC-null targets, NK cell-dependent clearance of missing-self targets 228 can discriminate between normal levels and partial down-regulation of MHC molecules in the context of 229 MCMV infection. 230
231
Deletion of MCMV genes m06 and m152 prevents NK-dependent clearance while enhancing CD8 + T 232 cell-dependent protection 233
To determine if m06 and m152 perturb NK-dependent viral resistance, we generated an independent 234 set of Δm157-MCMV stocks in a virulent MCMV strain with mutations in both m06 and m152, termed 235
Δm157/Δm06/Δm152-MCMV. Δm157-MCMV and Δm157/Δm06/Δm152-MCMV showed similar rates of 236 in vitro growth and viral titers, though Δm157-MCMV had a slight advantage (Fig S6) . Regardless, 237 infection of Rag1 -/mice on the B6 background indicated that both viruses had comparable replication in vivo (Fig 5F) . By contrast, Δm157/Δm06/Δm152-MCMV infection of B6 and ΔLy49-1 D8-KODO mice, 239 otherwise susceptible to Δm157-MCMV (Fig 1B, 2B) , resulted in a resistant phenotype (Fig 5F, 5G) . D8-240 KODO mice were also resistant to Δm157/Δm06/Δm152-MCMV but resistance was not dependent on 241 NK cells (Fig 5G) , contrasting their NK cell-dependent resistance to ∆m157-MCMV (Fig 1C) . Instead, CD8 242 depletion significantly reversed resistance to Δm157/Δm06/Δm152-MCMV (Fig 5G) , unlike the absence 243 of an effect on resistance to ∆m157-MCMV (Fig 1C) . evolved alleles of its ORFs that modulate these processes.
Our studies suggest that MCMV should encode molecules to specifically inhibit licensed NK cells. Indeed, 264 MCMV-encoded m157 can engage Ly49 inhibitory receptors in mouse strains that do not have Ly49H 265 activation receptor-equivalents; e.g. Ly49I in 129 mice [15] and Ly49C in BALB/c [20] . We predict that 266 m157 inhibition of NK cell function will depend on whether these inhibitory receptors are in hosts with 267 appropriate MHC-I alleles for licensing. Indeed, m157 effects on inhibiting NK cell control appear to be 268 MHC-dependent [20] , suggesting such potential interactions. Moreover, MCMV has 11 ORFs with 269 predicted MHC-I folds [38] , some of which have been verified by crystallographic studies, and thus may 270 be similarly involved in modulating NK cells. Prior findings have suggested that upon downmodulation of 271 MHC-I via m06 and m152, a third immunoevasin (m04) acts to stabilize certain MHC-I alleles on the 272 surface of infected cells, leading to NK cell-dependent resistance, depending on additional activation 273 receptors [19] . However, our studies do not show an apparent role for m04, indicating the MHC-I-274
restricted, inhibitory NK cell receptor-dependent anti-viral effects described here are fundamentally and 275 mechanistically different from prior reports. 276 277 Beyond viral control, our studies also establish that Ly49 inhibitory receptors play a critical role in 278 missing-self rejection, as previously predicted, based on in vitro observations and mice with global 279 defects in MHC-I expression that have unlicensed NK cells. Here we clearly show that absence of specific 280 inhibitory Ly49 receptors in a mouse expressing MHC-I results in unlicensed NK cells and an inability to 281 perform missing-self rejection. It should be noted that prior studies of Ly49 specificities were often 282 dependent on overexpression systems that may not reflect physiological interactions. Understanding of 283 these ambiguities will be aided by the Ly49 KO mice described here as well as complementation by 284 restoring expression of a single Ly49 receptor. Taken together, these data also provide definitive 285 evidence that the inhibitory receptors are required for missing-self rejection in vivo.
As in viral control, NK cell effects on tumor control greatly rely on both NK cell activation and inhibitory 288 receptor signaling [39] . MHC-I downmodulation during tumor growth to evade CTLs provides an 289 attractive target for oncogenic control, yet the in vivo requirements for this potential critical function 290 are poorly understood. Indeed, we recently showed that missing-self rejection in a mouse with inducible 291 β2m deletion is markedly enhanced by inflammatory stimuli, such as MCMV infection, otherwise 292 licensed NK cells can lose the licensed phenotype when profound MHC-I deletion occurs [37] , consistent 293 with results reported here. Therefore, our studies on NK cell control of viral infection, demonstrating of 294 the complex in vivo interaction between inhibitory receptors and self-MHC-I, can serve as an analogous 295 framework for considering how to modulate NK cells for controlling cancer.
Methods 297
Mice 298 C57BL/6Ncr (B6) and BALB/cAnNCr (BALB/c) mice were purchased from Charles River 299
Laboratories. C57BL/10SnJ (B10; 000666), B10.D2/nSnJ (B10.D2; 000666), Prf1 -/-(002407) and RAG1 -/-300 (002216) strains were purchased from Jackson Laboratory. DAP10 -/-DAP12 -/mice were provided by T. 301
Takai [40] . NKG2D -/mice were obtained from Bolan Polic (University of Rijeka, Croatia) [23] . Granzyme 302 B KO mice were obtained from T. Ley (Washington University, St. Louis) [41] . and Infectious Diseases, Bethesda, MD). D8-KODO mice were generated by crossing D8-transgenic mice 307 to KODO mice. Generation and characterization of the ITIM-mutant AYF mice on the H2 d background 308
have been previously described [31] . KLRA7 em1(IMPC)J (Ly49G KO) mice on the C57BL/6NJ background were 309 purchased from the Jackson Laboratory (027444); this allele was generated at the Jackson Laboratory by 310 CRISPR-Cas9 injection of Cas9 RNA and 3 gRNAs: TCTTGTACTTGTGCATAACC, CAGTCCTCACTAGTTTCTGC 311 and GACATGGACTGACCAAATT resulting in a 241 bp deletion beginning in 5-prime upstream sequence 312 and ending within exon 1. Additional strains of mice generated through CRISPR-Cas9 are described 313 below. All mice, with the exception of the RAG -/strain, used in these studies were initially obtained or 314 generated on the B6 genetic background and later backcrossed to the KODO and then D8-KODO 315 background (H2D d MHC). B6 mice used in experiments were obtained directly from Charles River 316
Laboratories. All other experimental and control mice were bred in-house at Washington University. While NCBI BLAST (http://blast.ncbi.nlm.nih.gov/) was initially used to assess sequence similarity of 325 potential sgRNAs, GT-Scan (https://gt-scan.csiro.au/gt-scan) [43] and CCTop (https://crispr.cos.uni-326 heidelberg.de/) [44] were primarily used to confirm the correct and specific targeting our sgRNA 327 designs. The sequences of synthetic guide RNAs (sgRNA) and the strains of mice generated are shown 328
in Table S1 . Cas9 mRNA and sgRNA synthesis, RNA micro-injection into zygotes is identical to what we 329 described earlier [45] . Specifically, we used 20ng of each guide when multiple guides were indicated, 330 and 100ng of Cas9 mRNA. Pups were screened for Ly49 gene disruption at birth by PCR. If multiple Ly49 331 alleles were present, they were separated by one backcross to B6 and re-screened by PCR. All mice with 332 in-frame insertions or deletions (indels) were excluded from further analysis. Multiple lines with out-of-333 frame indels were chosen for downstream characterization. These genetic lesions were verified by 334 absence of PCR amplicons for each of the indicated Ly49 genes in homozygous mice, and specific PCR 335 amplicons for the deleted genomic regions, that were sequenced to determine the exact breakpoints 336 (Fig S1 and Fig S2) . Finally, Ly49 protein expression was examined, where antibodies were available, at 8 337 weeks in homozygous mice following at least one additional backcross to parental B6. Since all sgRNAs 338 targeted the second exon of Ly49 genes, we focused on this exon to specifically interrogate on-target 339 and off-target analysis. As shown in Fig S1, all exons and the sgRNA with on-target and off-target 340 potential are depicted. Sanger sequence traces of homozygous mice are shown below the schematic. 341
Flow analysis across genes expressed within the NKC in D8-KODO mice is presented as Fig S2. Laboratory, however, full on-target, off-target (Fig S1) and flow cytometric (Fig S2) analyses was 347 performed by our laboratory. Importantly, no major impact on maturation was observed in any of these 348 mice. 349 350
Development of CRISPR-Cas9 modified Ly49A knockin mice 351
The NKp46 (Ncr1) locus was chosen for insertion of the Ly49A cDNA (Fig S3) . The donor construct was 352 designed to replace the stop codon of NKp46 (while maintaining the 3-prime untranslated region) with a 353 P2A peptide-cleavage site upstream of the Ly49A cDNA obtained from reverse transcription of Ly49A-354 expressing B6 NK cells. The result is that Ly49A expression would be restricted to all NK cells. Given that 355 the Ly49A knockin is located on chromosome 7, we were able to cross this mouse with the ΔLy49-1 356 mouse with Ly49 deletions on chromosome 6 without linkage restrictions. GT-Scan [43] and CCTop [44] 357 were primarily used to confirm the correct and specific targeting our sgRNA to the NKp46 locus. The 358 sequences of guide RNAs are shown in Table S1 . Cas9 mRNA and sgRNA synthesis, RNA and donor DNA 359 micro-injection is identical to what we described earlier [45] . Specifically, we used 10ng of donor DNA, 360 20ng of each guide (2 total), and 100ng of Cas9 mRNA. Pups were screened for the donor DNA by PCR 361 soon after birth and maintained as heterozygotes for flow-based confirmation at 8 weeks. After two 362 rounds of B6 backcrossing, the mice were bred to ΔLy49-1 D8-KODO. Mice homozygous for the NKC 363 deletion but heterozygous for the Ly49A knockin were screened for expression of Ly49A (Fig S3) . 364 Subsequently, various NKC surface molecules were analyzed by flow cytometry (Fig S2) . Again, no major 365 impact on maturation was observed. 366
Development of CRISPR-Cas9 modified MCMV 368
Δm157-MCMV and GFP-expressing MCMV were modified to knock-out various viral ORFs using CRISPR-369 Cas9 editing to obviate the need for bacterial artificial chromosome modification. The GFP-expressing 370 MCMV was a generous gift from S.C. Henry and J. Hamilton (Duke University, Durham, NC, USA) [46] and 371 previously described by our lab to harbor a non-functional m157 gene [47] . The GFP-expressing MCMV 372 and CRISPR-derived progeny were used in in vitro studies while the Δm157-MCMV derived from WT1 373 [48] and its CRISPR-modified progeny were used in the in vivo analyses. CCTop [44] was used to identify 374 and confirm specific targeting our sgRNAs to the MCMV ORFs. The stand-alone version of CCTop was 375 loaded with the MCMV genome (GenBank Accession GU305914.1) to effectively eliminate off-target 376 cleavage potential. The table of all possible guide site for MCMV is provided ( Table S2 ). The pX330 377 vector [49, 50] was obtained from Addgene and modified by replacing the SbfI-PsiI site with the Neo 378 marker (SbfI-HincII fragment) from pCDNA3. The oligonucleotide duplexes containing single sgRNAs 379 specific for MCMV m06 or m152 (Table S3 ) were cloned into this vector that was subsequently 380 transfected into SV40-immortalized B6 MEFs with G418 selection. Parental virus was used to infect 381 these sgRNA and Cas9-expressing MEFs at a low MOI (0.1). Once confluent lysis was observed, viral 382 supernatants were used to reinfect B6 MEFs, individual plaques were picked, and sequence variants 383 were confirmed (Fig S5) . For double-deficient MCMV ORF knockouts, a pure stock of virus (e.g. m06 384 knockout) was used to infect MEFs expressing Cas9 and the alternate sgRNA of interest (e.g. m152). For 385 in vivo analysis, plaque-purified virus was used to generate salivary gland passaged stocks in BALB/c 386 mice as described above. Salivary gland-derived MCMV lacking m06, m152, and m157 was compared to 387 MCMV lacking m157 in a multi-step growth curve on NIH 3T12 (ATCC CCL-164) fibroblasts (MOI = 0.1). 388 Viral genome copies quantified from cell lysates and culture supernatants, as previously described [51] , 389 demonstrated that replication of the triple knock-out virus was unimpaired yet delayed slightly in overall 390 growth (Fig S6) . 391
Viral infection and quantification 393
The salivary gland propagated MCMV stocks were generated from purified and sequenced clones. was purchased from Abcam. Anti-Ly49A (JR9) was purified in our laboratory from hybridoma 422 supernatants and subsequently conjugated to biotin or FITC. The JR9 hybridoma was generously 423 provided by Jacques Roland (Pasteur Institute, Paris, France) [52] . Anti-Ly49C (4LO33) [53] was purified 424 in our laboratory from hybridoma supernatants and subsequently conjugated to biotin. The 4LO 425 hybridoma was generously provided by Suzanne Lemieux (Institut National de la Recherche Scientifique-426
Institut Armand-Frappier, Laval, Quebec, Canada). Anti-NK1.1 (PK136) was purified in our laboratory 427 from hybridoma supernatants. The PK136 hybridoma was purchased from American Type Culture 428
Collection. Fc receptor blocking was performed with 2.4G2 (anti-FcγRII/III) hybridoma (American Type 429 Culture Collection) culture supernatants. Surface staining was performed on ice in staining buffer (1% 430 BSA and 0.01% NaN3 in PBS). Samples were collected using a FACSCanto (BD Biosciences), and data 431 were analyzed using FlowJo (TreeStar). 432 433
In vivo cytotoxicity 434
Mice used for donor splenocytes in in vivo cytotoxicity assays were 8-12 weeks old at the time of 435 transfer. WT-MCMV, where indicated, was inoculated 3 days prior at a dose of 10,000 pfu per mouse 436 [51] . Donor splenocytes were harvested and labeled in vitro with 2. 
NK cell in vitro stimulation and intracellular cytokine staining 447
Splenocytes were stimulated with anti-NK1.1 (PK136) as previously described [11] . Briefly, 24-well 448 culture plates were coated with 500 μL of purified PK136 (1 μg/mL). Plates were washed with PBS, and 5 449 × 10 6 splenocytes were then added to each well in 500 μL of R10 (RPMI 1640 supplemented with 10% 450 fetal bovine serum) media. Splenocytes were stimulated in parallel with 0.5 μg/mL PMA (Sigma-Aldrich) 451 and 4 μg/mL ionomycin (Sigma-Aldrich) and incubated at 37 °C and in 5% CO2 for a total of 7 h. Brefeldin 452 A (GolgiPlug; BD Biosciences) was added to the cells after 1 h. After staining surface antigens, cells were 453 fixed and permeabilized (Cytofix/Cytoperm; BD Biosciences) followed by staining for IFN-γ. NK cells were 454 gated as viable CD3 − CD19 − NKp46 + lymphocytes. 455 456 Sequence analysis 457 PCR amplicons were amplified with the Phusion high-fidelity DNA polymerase (NEB, Ipswich, MA) using 458 manufacturer recommended cycling conditions, column purified (Macherey-Nagel, Bethlehem, PA) and 459 were sequenced on an ABI 3730 at Genewiz, Inc (South Plainfield, NJ, USA). The resulting 460 chromatograms were aligned using SnapGene software (GSL Biotech, Chicago, IL) and the relevant 461 reference sequences for MCMV (GenBank Accession GU305914.1) or the C57BL/6 (GRCm38/mm10). All 462 oligonucleotides were synthesized by IDT (Coralville, IA).
Statistical analysis 465
Statistical analysis was performed using Prism (GraphPad software). Unpaired, two-tailed Student's t-466 tests were used to determine statistically significant differences between experimental groups. For all t- The authors declare no competing financial interests. Genomic DNA was isolated from back-crossed H2D d CRISPR-Cas9 modified mice used in these studies.
Figure Legends
The specific CRISPR-targeted exons (those with homology to the ITIM) were Sanger sequenced as representative of the most likely position of off-target effects and to confirm and characterize the frameshift in on-target variants. The primers used for PCR and subsequent sequence analysis are shown in Table S4 . (A) CRISPR knockin strategy for Ly49A expression on NKp46-expressing cells. 2 CRISPR guides, T1 and T3 (Table S1) were injected into B6 zygotes along with Cas9 mRNA and a donor DNA construct engineered to express the Ly49A cDNA following a P2A cleavage site such that the Ly49A expression would be proportional to NKp46 (Ncr1) transcript levels. (B) The final NKp46 TGA stop codon and several downstream bases (yellow highlighted region) in the coding region of exon 7 (blue text) were removed and replaced with a P2A site (purple text), Ly49A cDNA (red text) and finally the remainder of the NKp46 3' UTR sequence (green text). This donor vector with NKp46 homologous arms was co-injected with sgRNA for Ncr1 and Cas9 into B6 zygotes and positive knockin mice were selected at birth by PCR analysis and confirmed at 6 weeks of age by flow cytometry. (C) One Ly49A KI line was crossed to the ΔLy49-1 D8-KODO mice (Fig 2A) heterozygous for one knockin allele and confirmed by flow cytometry.
Lymphocytes for splenic single cell suspensions were assessed for both NK1.1 and Ly49A expression.
Approximately 18% of NK cells from WT (D8-KODO) mice expressed Ly49A, while the ΔLy49-1 D8-KODO mice lacked all Ly49A expression unless expressing the Ly49A from the knockin construct (nearly 100% expression). As shown, Ly49A expression was restricted to NK1.1 + splenocytes. Table S5 . Each panel depicts the reference sequence above with the region of the ORF expanded for analysis. The Sanger alignments below for the viruses indicated are designated as to which strains (left of trace) were analyzed. Δm157-MCMV is the wild-type genome at these ORFs, for comparison. Red boxes indicate where inserted nucleotides were identified. Sequence analysis was confirmed in both the forward and reverse direction, however, only one direction is shown for clarity.
Fig S6. Multi-step growth curve
Multi-step in vitro growth kinetics of two strains of MCMV, as indicated. Cells and supernatants were harvested at the indicated days and quantified by real-time PCR. Data is a representative of two independent experiments with each data point performed in triplicate. All timepoints were shown to significantly different in terms of viral load (p < .0001); statistical analysis performed with a Student's t-Test. 
